Home > Insider Trading > Filing (0000899243-20-018765)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1351288	Gw Pharmaceuticals Plc	GWPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754125	B. Douglas Snyder	Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2020-07-06	9,804	$10.50	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2020.
Represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
The price reported is price per ordinary share converted from price per ADS.
Column 5 of Table I of the reporting person's Form 4 filed with the SEC on March 4, 2020 includes 57,492 ordinary shares underlying RSU style share options granted pursuant to the Issuer's Long-Term Incentive Plan, including (i) 19,908 ordinary shares vesting automatically in two equal installments on August 10, 2020 and 2021, (ii) 19,224 ordinary shares vesting automatically in two equal installments on February 26, 2021 and 2022, and (iii) 18,360 ordinary shares vesting automatically in three equal installments on March 1, 2021, 2022, and 2023. These ordinary shares have been excluded from Column 5 of this Form 4 and will be reported as each tranche is vested and automatically exercised.